06/27/22 7:00 AMOTC : AIMD clinical trialcovid-19Ainos Announces Positive Results from Preclinical Studies of Its Low-dose Oral Interferon Formulation Against COVID-19Ainos, Inc. (OTC PINK: AIMD) ("Ainos", or the "Company"), a diversified medtech company focused on the development ofRHEA-AInegative
06/21/22 7:00 AMOTC : AIMD covid-19Ainos COVID-19 Antigen Self-Test Receives Approval for Sale in TaiwanAinos, Inc. (OTC PINK:AIMD) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced that theRHEA-AIneutral
12/07/21 6:55 PMOTC : AIMD Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus InfectionAinos, Inc. ("we", "our", or the "company"), (OTC PINK:AIMD), a diversified healthcare company engaged in the discovery and development of pharmaceutical, medical devices and biotech products announced it entered into a Development and Sales AgreementRHEA-AIneutral
11/03/21 12:00 PMOTC : AIMD Ainos SRNA Research Initiative Announces Milestones for mRNA Vaccine DevelopmentAinos, Inc. ("we", "our", or the "company"), (OTC PINK:AIMD), announced today that the company has recently achieved early stage milestones in its mRNA vaccine research and development initiative. The company's mRNA vaccine is designed against theRHEA-AIneutral
08/16/21 9:23 AMOTC : AIMD Ainos Elects Ms. Hui-Lan (Celia) Wu as CFO, Lawrence K. Lin as Executive Vice President of Operations, and Other Key ExecutivesAinos, Inc. ("we", "our", or the "Company"), (OTC PINK:AIMD), elected Ms. Hui-Lan (Celia) Wu as its new Chief Financial Officer ("CFO"). Ms. Wu succeeds Mr. Chun-Hsien Tsai who resigned from his CFO position but continues to serve as the Company'sRHEA-AIneutral
06/14/21 5:20 PMOTC : AIMD covid-19Ainos Named Exclusive Sales Partner for COVID-19 Antigen Rapid Test Kit in TaiwanAinos, Inc. ('we', 'our', or the 'Company'), (OTC PINK:AIMD), entered into an exclusive agreement to serve as the master sales and marketing agent for the Ainos SARS-CoV-2 Antigen Rapid Test Kit ("Covid-19 Test Kit") for Taiwan Carbon Nano CorporationRHEA-AIvery positive
05/24/21 10:40 AMOTC : AMAR, AIMD Ainos Announces FINRA Approval of Name Change and Ticker Symbol Change to "AIMD", Engages Firm to Explore Listing Requirements of National Securities ExchangesAinos, Inc., f/k/a Amarillo Biosciences, Inc. ("we", "our", or the "Company"), (OTC PINK:AIMD), is pleased to announce that the Financial Industry Regulatory Authority, Inc. ("FINRA") approved the Company's name change to "Ainos, Inc." and "AIMD" as itsRHEA-AIneutral
